PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, featuring promising enhancements across several health-related and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, additional trustworthy substitute for therapeutic use